Publication | Closed Access

Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced

NanomedicineChemical EngineeringEngineeringNanomaterialsNanotechnologyTargeted DeliveryTherapeutic NanomaterialsNano-drug DeliveryArsenic TrioxideTumor TargetingRadiation OncologySurface-modified Plga Nanoparticles